• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Time to treat Chagas disease!

11 Jul 2009
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

Time to Treat Chagas Disease

In July 2009, on the occasion of the Centenary of the discovery of Chagas disease, DNDi launched a campaign to draw attention to the huge gaps in treatments for Chagas patients. ’Research on Neglected Diseases. Time to Treat Chagas Disease!’ brought to light the stark realities surrounding the disease.

  • Chagas Campaign flyer
  • More on Chagas disease

Campaign summary

About

The Chagas: Time to Treat Campaign was an international campaign launched by the Drugs for Neglected Diseases initiative (DNDi) on July 9 2009, the centennial of the discovery of Chagas disease, to advocate for access to existing treatments and increased research and development (R&D) of new, more effective and safer treatments for Chagas disease.

  • Watch videos from the campaign
  • Download presentations and information on Chagas disease from Chagas symposium, October 2, 2009

Background

Chagas disease is a potentially fatal neglected disease that affects between 8 and 10 million people worldwide. Chagas kills more people in Latin America than any other parasite-borne disease, including malaria.

Existing treatments for Chagas disease are not satisfactory and can have toxic side effects. What patients urgently needed in 2009 were affordable, safe, and efficacious diagnostics tools and treatments for children and adults as well as a drug that treats both stages of Chagas: acute and chronic. Access to treatment is also a problem: It has been estimated that less than 1% of Chagas disease patients receive any treatment at all.

Although 100 million people are at risk of being infected with Chagas disease, funding for R&D to improve treatments is extremely low, making it one of the most neglected of the neglected diseases. The campaign highlighted that in 2007, less than US$1 million (0.04% of R&D funding dedicated to neglected diseases) was spent on the development of new drugs for Chagas disease. Unfortunately, these numbers have not changed significantly since then.

The campaign

The Chagas: Time to Treat campaign brought together partners with the following aims:

  1. Prioritize Chagas in the agenda of policy makers and donors: It is time for effective political willingness.
  2. Raise awareness on the disease and its reality: The silence around the disease must be broken.
  3. Boost R&D for new tools for the disease: New tools and sustainable mechanisms are urgently needed to allow new diagnostics and treatment.

The campaign incorporated many different tools to achieve its goals, such as participation in key congresses on Chagas and other neglected diseases, advocacy strategies in crucial meetings at the World Health Organization (WHO) and Pan-American Health Organization (PAHO) and engagement in public events

Key outcomes

R&D for new treatments and tools for the disease

  • Discussions among the Chagas disease scientific community gave birth to the Chagas Clinical Research Platform
  • Significant boost in DNDi portfolio of R&S projects with new partners in the pharmaceutical industry mobilized with the cause;
  • Increase of Chagas projects within the MSF network: Paraguay, Colombia and USA;
  • Registration in 2011 of a most needed paediatric formulation of benznidazole to treat Chagas disease in children;

Chagas disease in the agenda of policy makers and donors

  • World Health Organization & the Pan American Health Organization adopted Chagas resolutions recognizing the need for treatment as well as R&D;
  • US congressional support for a Chagas resolution;
  • Funding opportunities for NTDs increased with new opportunities for grants;

Awareness raised on the disease and its reality

  • Documentaries, movies, short testimonials and addresses to the general media launched;
  • A number of cutting edge scientific articles and publications;
  • In Latin America, the campaign joined the momentum created by the 100th anniversary, and inspired a sense of activism within the scientific and medical community;
  • The Chagas community put forward a call to action and is clearly engaging advocacy awareness for this disease;
  • Chagas patients mobilized around associations and a world federation;


The level of engagement achieved by the Campaign continued to grow in the following years leading to, in December 2012, the launch of the Global Chagas Disease Coalition: an open, ambitious, collaborative alliance where, together and through the sharing of expertise, knowledge, and capacity for action, hopes to achieve the goal of alleviating human suffering caused by Chagas disease and ultimately, controlling Chagas disease once and for all.

The Global Chagas Disease Coalition includes Drugs for Neglected Diseases initiative (DNDi), Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development and National School of Tropical Medicine at Baylor College of Medicine, Fundación Mundo Sano, CEADES, and ISGlobal, with the support of Médecins Sans Frontières (MSF), Instituto Carlos Slim de la Salud, the Los Angeles Olive Hospital and the International Federation of People Affected by Chagas Disease (FINDECHAGAS).

The future

Improving treatments and access to treatment for Chagas patients remains an urgent need. Find out more about what DNDi and its partners are doing for Chagas disease at DNDi’s global website and DNDi Latin America’s website.

The partners

InstitutionCountry
Médecins Sans Frontières (MSF) – DNDi Founding PartnerInternational
Fiocruz – DNDi Founding PartnerBrazil
Institut Pasteur – DNDi Founding PartnerFrance
Indian Council of Medical Research – DNDi Founding PartnerIndia
Kenya Medical Research Institute (KEMRI) – DNDi Founding PartnerKenya
Ministry of Health – DNDi Founding PartnerMalaysia
WHO Special Programme for Research and Training in Tropical Diseases (TDR) – Permanent Observer of DNDiInternational
Asociación de Amigos de las Personas con la Enfermedad de Chagas (ASAPECHA)Spain
Asociación de Lucha contra el Mal de Chagas (ALCHA)Argentina
Ambulatório Chagas/ICC (PROCAPE-UPE)Brazil
Australian Chagas’s Disease AssociationAustralia
Fundación Amigos con Chagas (Fundachagas)enezuela
Fundación Mundo SanoArgentina
Laboratório Farmacêutico do Estado de Pernambuco (LAFEPE)Brazil
Olive View UCLA Medical CenterUSA
The Chagas Disease FoundationUSA
Universities Allied for Essential Medicines (UAEM)Canada
Sociedad Parasitológica VenezolanaVenezuela
Prefeitura de LassanceBrazil
International Federation of Medical Students’ Asssociations (IFMSA)Brazil
Royal Tropical Institute – KITNetherlands
The Cinema GuildUSA
Preve filmsUSA

These partnered collaborations made possible the achievement of several successful outcomes and led to, in many cases, sustainable and fruitful future relationships.

Policy advocacy Chagas disease

Read, watch, share

Loading...
Centre of Excellence in India
News
14 Sep 2023

DNDi’s Centres of Excellence: Towards the sustainable elimination of visceral leishmaniasis in India

Delali Attip
Press releases
6 Sep 2023

Biotech leader Delali Attiogbe Attipoe joins DNDi as North America Director

Viewpoints
5 Sep 2023

Africa should bolster research into climate-sensitive diseases

Context
Prof. Sam Kariuki, DNDi Eastern Africa Director and Leonard Ithau, Rotary International District 9212 District Governor shaking hands
News
29 Aug 2023

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

Mother and child in a hospital
Viewpoints
24 Aug 2023

A drug development model for the diseases the world forgot

Africa Arguments
Statements
21 Aug 2023

DNDi urges G20 to operationalize equity in response to major global health challenges and priorities

Man looking into a microscope
Press releases
31 Jul 2023

Certara and DNDi partnering to fast-track data submissions and accelerate drug approvals for neglected patients

DNDi Prof. Fahal Interview 2023 Cover Image
Videos
25 Jul 2023

Prof. Fahal On The 20 Years of Innovating Together In Helping Mycetoma Patients

VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
This website uses necessary cookies to function. If you give your consent, we will also use statistical, functional, and marketing cookies. See Cookie Policy.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo